These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3904407

  • 1. Renal function and somatic growth in pediatric cadaveric renal transplantation with cyclosporine-prednisone immunosuppression.
    Ellis D, Avner ED, Rosenthal JT, Taylor RJ, Young LW, Palumbi MA, Hakala TR.
    Am J Dis Child; 1985 Nov; 139(11):1161-7. PubMed ID: 3904407
    [Abstract] [Full Text] [Related]

  • 2. Use of cyclosporine in pediatric renal transplant recipients.
    Conley SB, Flechner SM, Rose G, Van Buren CT, Brewer E, Kahan BD.
    J Pediatr; 1985 Jan; 106(1):45-9. PubMed ID: 3880820
    [Abstract] [Full Text] [Related]

  • 3. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years.
    Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT.
    Transplantation; 1987 Feb; 43(2):197-204. PubMed ID: 3544376
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
    Martin DC, Tertzakian G, Ruzics E.
    J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
    [Abstract] [Full Text] [Related]

  • 5. Short-term and long-term function of cadaveric kidneys from pediatric donors in recipients treated with cyclosporine.
    Smith AY, Van Buren CT, Lewis RM, Kerman RH, Kahan BD.
    Transplantation; 1988 Feb; 45(2):360-7. PubMed ID: 3278429
    [Abstract] [Full Text] [Related]

  • 6. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
    Sumrani N, Delaney V, Ding ZK, Butt K, Hong J.
    Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
    [Abstract] [Full Text] [Related]

  • 7. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants.
    Barry JM, Shively N, Hubert B, Hefty T, Norman DJ, Bennett WM.
    Transplantation; 1988 Feb; 45(2):346-8. PubMed ID: 3278427
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants.
    Gordon RD, Iwatsuki S, Shaw BW, Starzl TE.
    Am J Kidney Dis; 1985 Jun; 5(6):307-12. PubMed ID: 3893105
    [Abstract] [Full Text] [Related]

  • 9. Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone.
    Reisman L, Lieberman KV, Burrows L, Schanzer H.
    Transplantation; 1990 Jan; 49(1):76-80. PubMed ID: 2301032
    [Abstract] [Full Text] [Related]

  • 10. Improving results of pediatric renal transplantation.
    Shapiro R, Tzakis A, Scantlebury V, Jordan M, Vivas C, Ellis D, Gilboa N, Irish W, Hopp L, Reyes J.
    J Am Coll Surg; 1994 Oct; 179(4):424-32. PubMed ID: 7522851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low-dose cyclosporine for cadaveric renal transplantation.
    Vanderwerf BA, Serota AI.
    Transplantation; 1988 Feb; 45(2):320-3. PubMed ID: 3278422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation.
    So SK, Najarian JS, Nevins TE, Fryd DS, Knaak M, Chavers B, Mauer SM, Simmons RL.
    J Pediatr; 1987 Dec; 111(6 Pt 2):1017-21. PubMed ID: 3316573
    [Abstract] [Full Text] [Related]

  • 16. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
    Leone MR, Alexander SR, Melvin T, Striegel J, Reller K, Norman DJ, Barry JM.
    J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
    [Abstract] [Full Text] [Related]

  • 17. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
    Lewis RM, Johnson PC, Golden D, Van Buren CT, Kerman RH, Kahan BD.
    Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 20. The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine.
    Miwa H, Van Loenen M, Vanderwerf BA.
    Clin Transpl; 1989 Feb; ():275-80. PubMed ID: 2487572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.